Unusual lymphomas: Unusual sites

Lymphomas, both Hodgkin’s and Non-Hodgkin’s, are malignant neoplasms of lymphocytes which usually involve lymph nodes, bone marrow, and extranodal sites. With the advent of adjuvant chemotherapy, lymphomas (most subtypes) have now shifted from the category of fatal hematological neoplasms to the category of treatable hematological neoplasms. Many lymphomas, however, still need to be treated aggressively and promptly making the diagnosis quintessential. However, diagnosis is very challenging in cases presenting at unusual sites with unusual morphologies. Biopsy and immunohistochemistry remain the initial most investigative modalities to document the diagnosis; thus, the histopathologist needs to be alert of the “not-so-common” lymphomas. We discuss here four cases that have posed great challenge in diagnosis and included in this case series. However, recent World Health Organization classification recognizes the significance of genetic and molecular data in the evaluation of a lymphoid neoplasm. Where in, it ascertains a neoplasm into a category, family/class, entity/type, and subtype. This has been formulated in such a manner that it is possible in settings globally; however, consideration is given to the fact that these resources are not universally available.

Authors

Institutions

Publication Details

Journal
Journal of Hematology and Allied Sciences
Published
2025-06-07
DOI
https://doi.org/10.25259/jhas_13_2025
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unusual lymphomas: Unusual sites

Kaushal Kalra, Sana Ahuja, Neha Kawatra Madan, Meetu Agrawal et al.
Journal of Hematology and Allied Sciences
Lymphoma Diagnosis and Treatment
article

Unusual lymphomas: Unusual sites

Kaushal Kalra, Sana Ahuja, Neha Kawatra Madan, Meetu Agrawal, Ajay Joseph Kaveripakam
article en

Abstract

Lymphomas, both Hodgkin’s and Non-Hodgkin’s, are malignant neoplasms of lymphocytes which usually involve lymph nodes, bone marrow, and extranodal sites. With the advent of adjuvant chemotherapy, lymphomas (most subtypes) have now shifted from the category of fatal hematological neoplasms to the category of treatable hematological neoplasms. Many lymphomas, however, still need to be treated aggressively and promptly making the diagnosis quintessential. However, diagnosis is very challenging in cases presenting at unusual sites with unusual morphologies. Biopsy and immunohistochemistry remain the initial most investigative modalities to document the diagnosis; thus, the histopathologist needs to be alert of the “not-so-common” lymphomas. We discuss here four cases that have posed great challenge in diagnosis and included in this case series. However, recent World Health Organization classification recognizes the significance of genetic and molecular data in the evaluation of a lymphoid neoplasm. Where in, it ascertains a neoplasm into a category, family/class, entity/type, and subtype. This has been formulated in such a manner that it is possible in settings globally; however, consideration is given to the fact that these resources are not universally available.

Journal of Hematology and Allied SciencesVol. 5
Vardhman Mahavir Medical College & Safdarjung Hospital (IN)
Openalex Percentile: Top 81%
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Unusual lymphomas: Unusual sites — Kaushal Kalra, Sana Ahuja, et al. · Journal of Hematology and Allied Sciences (2025) | TGRS Research Map | TGRS